trending Market Intelligence /marketintelligence/en/news-insights/trending/SbWokrbokRav4FvrR_bkyg2 content esgSubNav
In This List

Thermo Fisher's Zika diagnosis kit gets emergency FDA authorization

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Thermo Fisher's Zika diagnosis kit gets emergency FDA authorization

The U.S. Food and Drug Administration authorized the emergency use of Thermo Fisher Scientific Inc.'s Zika virus diagnosis kit.

The authorization for the company's TaqPath Zika kit only covers the diagnosis of that particular virus and is not meant to be used for the diagnosis of any other infection.

It has not been FDA-cleared or approved and can only be used by certified laboratories.